Envestnet Asset Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-66,910
Closed -$396K 4518
2025
Q2
$396K Buy
66,910
+11,399
+21% +$65.6K ﹤0.01% 3868
2025
Q1
$355K Buy
55,511
+8,249
+17% +$79.5K ﹤0.01% 3826
2024
Q4
$561K Buy
47,262
+25,620
+118% +$437K ﹤0.01% 3521
2024
Q3
$599K Buy
+21,642
New +$541K ﹤0.01% 3442
2024
Q1
Sell
-12,815
Closed -$202K 4179
2023
Q4
$202K Sell
12,815
-424
-3% -$4.38K ﹤0.01% 3822
2023
Q3
$114K Sell
13,239
-1,917
-13% -$13.6K ﹤0.01% 3852
2023
Q2
$120K Buy
15,156
+4,116
+37% +$28.6K ﹤0.01% 3815
2023
Q1
$82.2K Buy
11,040
+618
+6% +$6.14K ﹤0.01% 3816
2022
Q4
$123K Buy
+10,422
New +$119K ﹤0.01% 3778

Other funds holding ASPN

Envestnet Asset Management's ASPN Position: Q3 2025 in Review

Envestnet Asset Management sold out of Aspen Aerogels (ASPN) in Q3 2025, closing a stake of 66,910 shares — an estimated $396K sold.

Envestnet Asset Management first reported a position in ASPN in Q4 2022 and held it in 9 quarters. The position peaked at $599K in Q3 2024. 204 funds tracked by Wall St. Rank hold ASPN as of Q3 2025.

  • Envestnet Asset Management reported no remaining Aspen Aerogels position as of Q3 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 66,910 Aspen Aerogels shares in Q3 2025, an estimated $396K.
  • Envestnet Asset Management first reported a position in Aspen Aerogels in Q4 2022 and held it in 9 quarters.
  • Envestnet Asset Management's Aspen Aerogels position peaked at $599K in Q3 2024.
  • 204 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2025.

Based on Envestnet Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.